
Physidia
Home hemodialysis.
Date | Investors | Amount | Round |
---|---|---|---|
investor | €0.0 | round | |
* | N/A | Buyout | |
Total Funding | 000k |

EUR | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% growth | - | 62 % | 37 % | 55 % | 54 % | 50 % | 32 % |
EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% EBITDA margin | (62 %) | (79 %) | (69 %) | (39 %) | (14 %) | (14 %) | - |
Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% profit margin | (111 %) | (62 %) | (76 %) | (65 %) | (37 %) | (18 %) | (19 %) |
EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Physidia specializes in providing innovative home dialysis solutions aimed at improving the quality of life for patients with chronic renal failure. The company focuses on daily home hemodialysis, allowing patients to integrate their treatment seamlessly into their daily lives, thus promoting comfort and independence. Physidia serves individuals suffering from renal insufficiency, offering them a choice to manage their condition from the comfort of their homes. Operating in the healthcare market, particularly in the renal care segment, Physidia's business model revolves around the sale and support of its dialysis equipment and services. The company generates revenue through the direct sale of its dialysis machines, ongoing maintenance services, and customer support. By prioritizing patient comfort and freedom, Physidia aims to transform the traditional approach to dialysis treatment.
Keywords: home dialysis, chronic renal failure, hemodialysis, patient independence, renal care, healthcare innovation, dialysis equipment, patient comfort, renal insufficiency, daily treatment.